Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Bunchai Chongmelaxme, Maythika Hammanee, Wariya Phooaphirak, Surachai Kotirum, Raymond Hutubessy & Nathorn Chaiyakunapruk. (2017) Economic evaluations of Haemophilus influenzae type b (Hib) vaccine: a systematic review. Journal of Medical Economics 20:10, pages 1094-1106.
Read now
Read now
Ulla K Griffiths & Alec Miners. (2009) Economic evaluations of Haemophilus influenzae type b vaccine: systematic review of the literature. Expert Review of Pharmacoeconomics & Outcomes Research 9:4, pages 333-346.
Read now
Read now
Bradford D Gessner. (2009) Haemophilus influenzae type b vaccine impact in resource-poor settings in Asia and Africa. Expert Review of Vaccines 8:1, pages 91-102.
Read now
Read now
Judith Galtry. (2002) Child health: An underplayed variable in parental leave policy debates?. Community, Work & Family 5:3, pages 257-278.
Read now
Read now
Articles from other publishers (16)
Rebecca Masters, Elspeth Anwar, Brendan Collins, Richard Cookson & Simon Capewell. (2017) Return on investment of public health interventions: a systematic review. Journal of Epidemiology and Community Health 71:8, pages 827-834.
Crossref
Crossref
Phuc Le, Ulla K. Griffiths, Dang Duc Anh, Luisa Franzini, Wenyaw Chan & J. Michael Swint. (2015) Cost-effectiveness of Haemophilus influenzae type b vaccine in Vietnam. Vaccine 33:36, pages 4639-4646.
Crossref
Crossref
Ulla Kou Griffiths, Andrew Clark & Rana Hajjeh. (2013) Cost-Effectiveness of Haemophilus influenzae Type b Conjugate Vaccine in Low- and Middle-Income Countries: Regional Analysis and Assessment of Major Determinants. The Journal of Pediatrics 163:1, pages S50-S59.e9.
Crossref
Crossref
Terri B. Hyde, Holly Dentz, Susan A. Wang, Helen E. Burchett, Sandra Mounier-Jack & Carsten F. Mantel. (2012) The impact of new vaccine introduction on immunization and health systems: A review of the published literature. Vaccine 30:45, pages 6347-6358.
Crossref
Crossref
Ulla K. Griffiths, Andrew Clark, Veronika Shimanovich, Irina Glinskaya, Dilorom Tursunova, Lucia Kim, Liudmila Mosina, Rana Hajjeh & Karen Edmond. (2011) Comparative Economic Evaluation of Haemophilus influenzae Type b Vaccination in Belarus and Uzbekistan. PLoS ONE 6:6, pages e21472.
Crossref
Crossref
Å Örtqvist, M Blennow, R‐M Carlsson, LÅ Hanson, A Lindberg, L Lindqvist, M Magnusson, L Nilsson, A Norlund, O Nyrén, P Olcén, P Olin, S‐A Silfverdal, J Säwe, A Söderström & B Trollfors. (2010) ORIGINAL ARTICLE: Vaccination of children – a systematic review. Acta Paediatrica 99:s461, pages 1-192.
Crossref
Crossref
Jessica C. Shearer, Meghan L. Stack, Marcie R. Richmond, Allyson P. Bear, Rana A. Hajjeh & David M. Bishai. (2010) Accelerating Policy Decisions to Adopt Haemophilus influenzae Type b Vaccine: A Global, Multivariable Analysis. PLoS Medicine 7:3, pages e1000249.
Crossref
Crossref
Bradford D. Gessner, Endang R. Sedyaningsih, Ulla K. Griffiths, Agustinus Sutanto, Mary Linehan, Dave Mercer, Edward Kim Mulholland, Damian G. Walker, Mark Steinhoff & Mardiati Nadjib. (2008) Vaccine-Preventable Haemophilus influenza Type B Disease Burden and Cost-Effectiveness of Infant Vaccination in Indonesia. Pediatric Infectious Disease Journal 27:5, pages 438-443.
Crossref
Crossref
A.E. Platonov, U.K. Griffiths, M.V. Voeykova, O.V. Platonova, I.L. Shakhanina, G.G. Chistyakova & S.E. Robertson. (2006) Economic evaluation of Haemophilus influenzae type b vaccination in Moscow, Russian Federation. Vaccine 24:13, pages 2367-2376.
Crossref
Crossref
Richard D. Rheingans, Johan Heylen & Carlo Giaquinto. (2006) Economics of Rotavirus Gastroenteritis and Vaccination in Europe. Pediatric Infectious Disease Journal 25:1, pages S48-S55.
Crossref
Crossref
Isabelle Chabot, Mireille M. Goetghebeur & Jean-Pierre Grégoire. (2004) The societal value of universal childhood vaccination. Vaccine 22:15-16, pages 1992-2005.
Crossref
Crossref
REGINA BRINSMEAD, SUZANNE HILL & DAMIAN WALKER. (2004) Are economic evaluations of vaccines useful to decision-makers? Case study of Haemophilus influenzae type b vaccines. The Pediatric Infectious Disease Journal 23:1, pages 32-37.
Crossref
Crossref
Giuseppe Giammanco & S. Pignato. (2013) Aspetti economici della vaccinazione per la prevenzione delle meningiti da Haemophilus influenzae tipo b nell’infanzia: scenari possibili in ItaliaEconomic considerations on Haemophilus influenzae type b meningitis prevention by childhood vaccination in Italy. PharmacoEconomics Italian Research Articles 5:S1, pages 39-46.
Crossref
Crossref
S.T. Casagrande, I.M. Landgraf, A.M.M. Kobata, R.C. Zanella & S. Bokermann. (2002) Antimicrobial resistance among invasive Haemophilus influenzae strains: results of a Brazilian study carried out from 1996 through 2000. Brazilian Journal of Medical and Biological Research 35:11, pages 1293-1300.
Crossref
Crossref
Marko Pokorn, Štefan Kopač, David Neubauer & Milan Čižman. (2001) Economic evaluation of Haemophilus influenzae type b vaccination in Slovenia. Vaccine 19:25-26, pages 3600-3605.
Crossref
Crossref
F. Javier Jiménez, Pilar Guallar-Castillón, Carlos Rubio Terrés & Eliseo Guallar. (2012) Cost-Benefit Analysis of Haemophilus influenzae Type b Vaccination in Children in Spain. PharmacoEconomics 15:1, pages 75-83.
Crossref
Crossref